EVINACUMAB
UNII T8B2ORP1DW

Substance Identification & Data

This profile provides standardized clinical and technical data for Evinacumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) T8B2ORP1DW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1446419-85-7 and the RxNorm Concept ID (RxCUI) 2478335. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

T8B2ORP1DW

CAS Registry Number

1446419-85-7

RxNorm Concept ID

2478335

Detailed Substance Profile

Preferred Name

EVINACUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

T8B2ORP1DW

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C169973

National Cancer Institute reference terminology for clinical and research data.

INN ID

10013

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

BC-26

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Evinacumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EVINACUMAB

EVINACUMAB-DGNB

Common Names & Synonyms

EVINACUMAB [INN]

EVINACUMAB [JAN]

EVINACUMAB [USAN]

EVINACUMAB [WHO-DD]

EVINACUMAB DGNB [WHO-DD]

IMMUNOGLOBULIN G4, ANTI-(HUMAN PROTEIN ANGPTL3 (ANGIOPOIETIN-LIKE 3)) (HUMAN MONOCLONAL REGN1500 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN1500 LIGHT CHAIN, DIMER